Literature DB >> 15677847

Bichat guidelines for the clinical management of plague and bioterrorism-related plague.

Philippe Bossi1, Anders Tegnell, Agoritsa Baka, Frank Van Loock, Jan Hendriks, Albrecht Werner, Heinrich Maidhof, Georgios Gouvras.   

Abstract

Yersinia pestis appears to be a good candidate agent for a bioterrorist attack. The use of an aerosolised form of this agent could cause an explosive outbreak of primary plague pneumonia. The bacteria could be used also to infect the rodent population and then spread to humans. Most of the therapeutic guidelines suggest using gentamicin or streptomycin as first line therapy with ciprofloxacin as optional treatment. Persons who come in contact with patients with pneumonic plague should receive antibiotic prophylaxis with doxycycline or ciprofloxacin for 7 days. Prevention of human-to-human transmission via patients with plague pneumonia can be achieved by implementing standard isolation procedures until at least 4 days of antibiotic treatment have been administered. For the other clinical types of the disease, patients should be isolated for the first 48 hours after the initiation of treatment.

Entities:  

Mesh:

Year:  2004        PMID: 15677847

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  4 in total

Review 1.  Resistance of Yersinia pestis to antimicrobial agents.

Authors:  Marc Galimand; Elisabeth Carniel; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

2.  Comparison of Etest method with reference broth microdilution method for antimicrobial susceptibility testing of Yersinia pestis.

Authors:  David R Lonsway; Sandra K Urich; Henry S Heine; Sigrid K McAllister; Shailen N Banerjee; Martin E Schriefer; Jean B Patel
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

3.  In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis.

Authors:  Jered M Wendte; Duraisamy Ponnusamy; Deanna Reiber; Jeffrey L Blair; Kenneth D Clinkenbeard
Journal:  Antimicrob Agents Chemother       Date:  2011-05-31       Impact factor: 5.191

4.  Continuous hypoxia reduces the concentration of streptomycin in the blood.

Authors:  Lin Chen; Zhancheng Gao
Journal:  BMC Infect Dis       Date:  2018-03-09       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.